$CC

Chemours options trading jumps to 5,376 contracts By Investing.com

Chemours Co. (NYSE:CC) options activity rose to 5,376 contracts by 2:51 p.m. ET Thursday, per exchange data compiled by Bloomberg. Calls were 4,348 and puts 1,028. The July 24, 2026 $22 call led with 2,619 contracts. CC shares fell 5.21% to $19.09.

Original reporting
Published Jul 2, 2026, 6:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 6:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$CC
Bearish
medium confidence
Mentioned
$CC
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CCBearishLow
01

Why it matters

The combination of a large options print, a down day in the stock, and a negative volatility skew points to elevated demand for downside protection and/or bearish speculation.

02

Market read

Traders may use the reported skew and put/call mix to gauge near-term volatility/hedging demand, but there is no new fundamental catalyst.

03

What to watch

The article doesn’t break out whether the flow is opening vs closing, nor does it provide catalysts for the -5.21% equity move—so directional inference is constrained.

Relevance 4/10Novelty 3/10Timing: intraday options flow reported by 2:51 p.m. ET on Thursday

Background

The piece reports intraday Chemours options positioning and contemporaneous share performance, citing exchange data compiled by Bloomberg.

Company-level read

Ticker impact

$CCBearishMedium confidence
Context

Chemours options volume jumped to 5,376 contracts by 2:51 p.m., with shares down 5.21% to $19.09.

Expected impact

Near-term downside risk remains elevated; expect continued volatility and put demand if price weakness persists.

Evidence & confidence

The article provides same-day spot move (-5.21%), total call/put counts, and a negative 90/110 skew (-0.58), all consistent with bearish positioning/hedging rather than a neutral flow.

Market effects

Limited sector read-through; this is primarily a single-name derivatives/price snapshot rather than a fundamental sector catalyst.

No clear regional spillover beyond US-listed Chemours trading/volatility.

Minimal global relevance; no international deal/regulatory or macro linkage is disclosed.

Counterpoint

Options volume can reflect hedging by existing holders rather than new bearish conviction, so the stock could stabilize if selling pressure fades.

Key entities

  • Chemours Co.

    Subject of the article; shares fell 5.21% to $19.09 and options activity reached 5,376 contracts by 2:51 p.m. ET.

Related articles

$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after its Q2 earnings. The company reported slight revenue decline and adjusted EPS of $0.42, down 31% year over year, meeting expectations. Management cited lower Optane refrigerant sales due to supply-chain inventory and the wind-down of the SPS Capstone business. Full-year growth guidance remains 1% to 5%.

$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after the company reported Q2 results. Revenue edged down and adjusted EPS fell 31% to $0.42, missing expectations. Lower Optane refrigerant sales and the prior wind-down of the SPS Capstone business weighed on results. Chemours still forecasts full-year growth of 1% to 5%.

$CCMedAI 8/10

The Chemours Company Reports Second Quarter Results

Chemours (NYSE: CC) reported Q2 2026 results: net sales about $1.6B, roughly flat year over year. Net loss attributable to Chemours was $274M ($1.81 per diluted share) versus $380M ($2.53) a year earlier. Adjusted net income was $64M ($0.42) and adjusted EBITDA $247M. Free cash flow rose 128% and net leverage fell to 4.4x. Chemours cited TiO2 pricing actions and APM Performance Solutions growth.

$CCMed

Chemours Co (CC): Results of Operations and Financial Condition

Chemours Co (CC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cc-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 The Chemours Company Reports Second Quarter Results Wilmington, Del., August 4, 2026 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Special

$MMMHighAI 9/10

New York sues 3M, DuPont and other chemical companies over PFAS pollution By Investing.com

New York Attorney General Letitia James sued 3M, DuPont, Chemours, Corteva and EIDP over alleged PFAS (“forever chemicals”) contamination. The complaint says the firms knew since decades-old research that PFAS were toxic but concealed risks, continued selling PFAS products, and allegedly misled consumers. New York seeks cleanup funding, consumer warnings, advertising changes, and damages and penalties.